BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29588585)

  • 1. Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases.
    Ganesan P; Ramalingam P; Karthivashan G; Ko YT; Choi DK
    Int J Nanomedicine; 2018; 13():1569-1583. PubMed ID: 29588585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson's disease models.
    Ganesan P; Ko HM; Kim IS; Choi DK
    Int J Nanomedicine; 2015; 10():6757-72. PubMed ID: 26604750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Nanoparticle-Mediated Delivery of Anti-Inflammatory Phytocompounds.
    Conte R; Marturano V; Peluso G; Calarco A; Cerruti P
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28350317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytobioactive compound-based nanodelivery systems for the treatment of type 2 diabetes mellitus - current status.
    Ganesan P; Arulselvan P; Choi DK
    Int J Nanomedicine; 2017; 12():1097-1111. PubMed ID: 28223801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-Based Nanoparticles in Delivering Bioactive Compounds for Improving Therapeutic Efficacy.
    Patel P; Garala K; Singh S; Prajapati BG; Chittasupho C
    Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plant-Derived Vesicle-like Nanoparticles: The Next-Generation Drug Delivery Nanoplatforms.
    Wang X; Xin C; Zhou Y; Sun T
    Pharmaceutics; 2024 Apr; 16(5):. PubMed ID: 38794248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: Nanostructured steady-state systems for nutrient and bioactive compounds delivery.
    Tan M; Abd El-Aty AM
    Front Nutr; 2024; 11():1421572. PubMed ID: 38835956
    [No Abstract]   [Full Text] [Related]  

  • 8. The Effects of Bioactive Compounds on Human Brain Structures and Diseases.
    Kiskova T; Smajda B
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies on Nanodiagnostics and Nanotherapies of the Three Common Cancers.
    Leng F; Liu F; Yang Y; Wu Y; Tian W
    Nanomaterials (Basel); 2018 Mar; 8(4):. PubMed ID: 29597315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DK1 Induces Apoptosis via Mitochondria-Dependent Signaling Pathway in Human Colon Carcinoma Cell Lines In Vitro.
    Hussin Y; Aziz MNM; Che Rahim NF; Yeap SK; Mohamad NE; Masarudin MJ; Nordin N; Abd Rahman NMA; Yong CY; Akhtar MN; Zamrus SNH; Alitheen NB
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29641445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of curcumin loaded chitosan/PEG blended PLGA nanoparticles for effective treatment of pancreatic cancer.
    Arya G; Das M; Sahoo SK
    Biomed Pharmacother; 2018 Jun; 102():555-566. PubMed ID: 29597089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid Lipid Nanoparticles: A Promising Nanomaterial in Drug Delivery.
    Rajpoot K
    Curr Pharm Des; 2019; 25(37):3943-3959. PubMed ID: 31481000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects.
    Scioli Montoto S; Muraca G; Ruiz ME
    Front Mol Biosci; 2020; 7():587997. PubMed ID: 33195435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol-Loaded Solid Lipid Nanoparticles Ameliorate the Inhibition of Proinflammatory Cytokines and Free Radicals in an In Vitro Inflammation-Induced Cell Model.
    Alcantara KP; Malabanan JWT; Nalinratana N; Thitikornpong W; Rojsitthisak P; Rojsitthisak P
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herbal Theranostics: Controlled, Targeted Delivery and Imaging of Herbal Molecules.
    Setia A; Vallamkonda B; Challa RR; Mehata AK; Badgujar P; Muthu MS
    Nanotheranostics; 2024; 8(3):344-379. PubMed ID: 38577318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical optimization of tetrahydrocurcumin loaded solid lipid nanoparticles using Box Behnken design in the management of streptozotocin-induced diabetes mellitus.
    Bharti Sharma J; Bhatt S; Tiwari A; Tiwari V; Kumar M; Verma R; Kaushik D; Virmani T; Kumar G; Al Kamaly O; Saleh A; Khalid Parvez M; Alhalmi A
    Saudi Pharm J; 2023 Sep; 31(9):101727. PubMed ID: 37638219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of Solid Lipid Nanoparticles in Breast Cancer Therapy.
    Mo K; Kim A; Choe S; Shin M; Yoon H
    Pharmaceutics; 2023 Jul; 15(8):. PubMed ID: 37631279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of Cancer Employing Chitosan, Its Derivatives, and Chitosan-Based Nanoparticles: Recent Updates.
    Virmani T; Kumar G; Sharma A; Pathak K; Akhtar MS; Afzal O; Altamimi ASA
    Polymers (Basel); 2023 Jul; 15(13):. PubMed ID: 37447573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knife's edge: Balancing immunogenicity and reactogenicity in mRNA vaccines.
    Lee J; Woodruff MC; Kim EH; Nam JH
    Exp Mol Med; 2023 Jul; 55(7):1305-1313. PubMed ID: 37430088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid Lipid Nanoparticles: Review of the Current Research on Encapsulation and Delivery Systems for Active and Antioxidant Compounds.
    Subroto E; Andoyo R; Indiarto R
    Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.